Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type

Leukemia and Lymphoma

Volumn 51, Issue 8, 2010, Pages 1509-1512

  Yokoyama, Hisayuki ^a   Yamamoto, Joji ^a   Tohmiya, Yasuo ^b   Yamada, Minami F ^a   Ohguchi, Hiroto ^a   Ohnishi, Yasushi ^a   Okitsu, Yoko ^a   Fukuhara, Noriko ^a   Ohba Ohtsuka, Rie ^a   Kohata, Katsura ^a   Ishizawa, Kenichi ^a   Kameoka, Junichi ^a   Harigae, Hideo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Miyagi Cancer Center   (Japan)

Author keywords

Allogeneic hematopoietic stem cell transplant; extranodal NK T cell lymphoma nasal type; l asparaginase

Indexed keywords

ASPARAGINASE; CALCINEURIN INHIBITOR; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISOLONE; TACROLIMUS; VINCRISTINE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RELAPSE; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEALTH STATUS; HUMAN; LONG TERM CARE; MALE; MORTALITY; MYELOABLATIVE CONDITIONING; NK T CELL LYMPHOMA; PRIORITY JOURNAL; PROPHYLAXIS; REMISSION; RETROSPECTIVE STUDY;

ADULT; ANTINEOPLASTIC AGENTS; ASPARAGINASE; COMBINED MODALITY THERAPY; CYCLOSPORINE; DRUG RESISTANCE, NEOPLASM; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, T-CELL; MALE; METHOTREXATE; NATURAL KILLER T-CELLS; NEOPLASM RECURRENCE, LOCAL; NOSE NEOPLASMS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955444558     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.487958     Document Type: Article

References (13)

1. Yamaguchi M, Tobinai K, Oguchi M, et al. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol 2009;27:5594-5600.
2. Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006;24:612-618.
3. Murashige N, Kami M, Kishi Y, et al. Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms. Br J Haematol 2005;130:561-567.
4. Suzuki R, Suzumiya J, Nakamura S, et al. Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transplant 2006;37:425-431.
5. Okamoto M, Maruyama F, Tsuzuki M, et al. Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide and carboplatin. Rinsho Ketsueki 1994; 35:635-641.
6. Wilson WH, Bryant G, Bates S, et al. EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. J Clin Oncol 1993;11:1573-1582.
7. Velasquez WS, McLaughlin P, Tucker S, et al. ESHAP-an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol 1994; 12:1169-1176.
8. Nagafuji K, Fujisaki T, Arima F, Ohshima K. L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation. Int J Hematol 2001;74:447-450.
9. Yokoyama H, Yamada MF, Ishizawa K, et al. Successful treatment of advanced extranodal NK/T cell lymphoma with unrelated cord blood transplantation. Tohoku J Exp Med 2007;211:395-399.
10. Kwong Y.L. High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies. Bone Marrow Transplant 2009;44:709-714.
11. Yamaguchi M, Suzuki R, Kwong YL, et al. Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Sci 2008;99:1016-1020.
12. Kim HJ, Bang SM, Lee J, et al. High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases. Bone Marrow Transplant 2006;37:819-824.
13. Mori Y, Aoki T, Takenaka K, et al. Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiation. Int J Hematol 2010;91:107-111.